• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小干扰RNA介导的细胞周期蛋白依赖性激酶8沉默抑制乳腺癌细胞的增殖和生长。

siRNA-mediated silencing of CDK8 inhibits proliferation and growth in breast cancer cells.

作者信息

Li Xiao-Yu, Luo Qi-Feng, Wei Chuan-Kui, Li Deng-Feng, Fang Lin

机构信息

Department of Breast and Thyroid Surgery, Shanghai Tenth People's Hospital, Tongji University Shanghai, 200072, China.

出版信息

Int J Clin Exp Pathol. 2013 Dec 15;7(1):92-100. eCollection 2014.

PMID:24427329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3885463/
Abstract

UNLABELLED

CDK8 is a cyclin-dependent kinase (CDK) member of the mediator complex that couples transcriptional regulators to the basal transcriptional machinery, and it has been investigated for possible tumor promoting functions. However, it is unclear whether CDK8 is involved in breast tumor cells growth. The aim of this study was to determine whether the suppression of CDK8 by small interfering RNA (siRNA) inhibits the growth of human breast cancer cell.

METHODS

CDK8-siRNA transfection was used to silencing the CDK8 gene in established breast cancer cell line, MDA-MB-231 and MCF-7, successful transfection being confirmed by Real-time PCR and could be shown by Western Blotting. CDK8 deletion caused significant decline in cell proliferation was observed in breast cancer cell lines as investigated by MTS assay, the number and size of the colonies formed were also significantly reduced in the absence of CDK8. Furthermore, transwell test were conducted to explore the migration of breast cancer cells. Moreover CDK8 gene knockdown arrested cell cycle.

RESULTS

CDK8 mRNA expression was reduced after transfection with CDK8-siRNA, and protein expression had a similar trend. Transfection of CDK8-siRNA suppressed breast cancer cells proliferation and migration; meanwhile the cells were arrested at G0/G1 phase.

CONCLUSIONS

CDK8 plays an essential role in breast cancer progression, which might inhibit the proliferation and migration in breast cancer cells.

摘要

未标记

CDK8是中介体复合物的一种细胞周期蛋白依赖性激酶(CDK)成员,它将转录调节因子与基础转录机制偶联起来,并且其促肿瘤功能已得到研究。然而,CDK8是否参与乳腺肿瘤细胞的生长尚不清楚。本研究的目的是确定小干扰RNA(siRNA)抑制CDK8是否会抑制人乳腺癌细胞的生长。

方法

采用CDK8-siRNA转染在已建立的乳腺癌细胞系MDA-MB-231和MCF-7中沉默CDK8基因,通过实时PCR确认成功转染,并通过蛋白质印迹法显示。通过MTS测定法研究发现,在乳腺癌细胞系中观察到CDK8缺失导致细胞增殖显著下降,在没有CDK8的情况下形成的集落数量和大小也显著减少。此外,进行Transwell试验以探究乳腺癌细胞的迁移。而且CDK8基因敲低使细胞周期停滞。

结果

用CDK8-siRNA转染后,CDK8 mRNA表达降低,蛋白质表达也有类似趋势。CDK8-siRNA转染抑制了乳腺癌细胞的增殖和迁移;同时细胞停滞在G0/G1期。

结论

CDK8在乳腺癌进展中起重要作用,可能抑制乳腺癌细胞的增殖和迁移。

相似文献

1
siRNA-mediated silencing of CDK8 inhibits proliferation and growth in breast cancer cells.小干扰RNA介导的细胞周期蛋白依赖性激酶8沉默抑制乳腺癌细胞的增殖和生长。
Int J Clin Exp Pathol. 2013 Dec 15;7(1):92-100. eCollection 2014.
2
Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells.细胞周期蛋白依赖性激酶 8 特异性 siRNA 对结肠癌细胞增殖和凋亡的影响。
J Exp Clin Cancer Res. 2011 Nov 22;30(1):109. doi: 10.1186/1756-9966-30-109.
3
siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells.小干扰RNA介导的NIN1/RPN12结合蛋白1同源物沉默抑制乳腺癌细胞的增殖和生长。
Asian Pac J Cancer Prev. 2012;13(5):1823-7. doi: 10.7314/apjcp.2012.13.5.1823.
4
The microRNA-141-3p/ CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab.微小 RNA-141-3p/CDK8 通路调控乳腺癌细胞对曲妥珠单抗的化疗敏感性。
J Cell Biochem. 2019 Aug;120(8):14095-14106. doi: 10.1002/jcb.28685. Epub 2019 May 14.
5
[The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].[小干扰RNA介导的Bmi-1基因沉默促进MCF-7乳腺癌细胞凋亡并抑制其侵袭]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Aug;32(8):1036-40.
6
ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.shRNA 介导的 MTA1 基因沉默对乳腺癌细胞系 MDA-MB-231 和 MCF-7 中 ERα、MMP-9、CyclinD1 和侵袭性、增殖的蛋白表达的影响。
J Exp Clin Cancer Res. 2011 May 19;30(1):60. doi: 10.1186/1756-9966-30-60.
7
[Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].[Oct4基因下调对MDA-MB-231乳腺癌干细胞生物学特性的影响]
Zhonghua Zhong Liu Za Zhi. 2015 Apr;37(4):251-7.
8
Silencing of DUSP6 gene by RNAi-mediation inhibits proliferation and growth in MDA-MB-231 breast cancer cells: an in vitro study.RNAi介导的DUSP6基因沉默抑制MDA-MB-231乳腺癌细胞的增殖和生长:一项体外研究。
Int J Clin Exp Med. 2015 Jul 15;8(7):10481-90. eCollection 2015.
9
The effects of p38 gene silencing on breast cancer cells.p38基因沉默对乳腺癌细胞的影响。
Mol Biol Rep. 2014 May;41(5):2923-7. doi: 10.1007/s11033-014-3148-z. Epub 2014 Jan 28.
10
[Knockdown of CART1 induces S phase arrest and inhibits invasion and migration of MDA-MB-231 breast cancer cells].[敲低CART1诱导S期阻滞并抑制MDA-MB-231乳腺癌细胞的侵袭和迁移]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Apr;32(4):474-8.

引用本文的文献

1
Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells.TKS4缺陷诱导的形态学变化可通过抑制EZH2在结肠癌细胞中逆转。
Biomolecules. 2024 Apr 5;14(4):445. doi: 10.3390/biom14040445.
2
Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical Models.乳腺癌:环状 RNA 介导临床前模型中的疗效。
Cancer Genomics Proteomics. 2023 May-Jun;20(3):222-238. doi: 10.21873/cgp.20377.
3
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.细胞周期蛋白与细胞周期蛋白依赖性激酶:从生物学特性到肿瘤发生及治疗机遇
J Cancer Res Clin Oncol. 2023 Apr;149(4):1585-1606. doi: 10.1007/s00432-022-04135-6. Epub 2022 Jul 4.
4
Frequent genetic defects in the p16/INK4A tumor suppressor in canine cell models of breast cancer and melanoma.在乳腺癌和黑色素瘤的犬科细胞模型中,p16/INK4A 肿瘤抑制基因经常发生遗传缺陷。
In Vitro Cell Dev Biol Anim. 2021 May;57(5):519-530. doi: 10.1007/s11626-021-00571-9. Epub 2021 May 20.
5
Pharmacological Inhibition of CDK8 in Triple-Negative Breast Cancer Cell Line MDA-MB-468 Increases E2F1 Protein, Induces Phosphorylation of STAT3 and Apoptosis.三阴性乳腺癌 MDA-MB-468 细胞系中 CDK8 的药理学抑制增加 E2F1 蛋白,诱导 STAT3 磷酸化和细胞凋亡。
Molecules. 2020 Dec 4;25(23):5728. doi: 10.3390/molecules25235728.
6
Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements.基于生物工程化小干扰RNA的纳米平台靶向分子信号通路治疗三阴性乳腺癌:临床前和临床进展
Pharmaceutics. 2020 Sep 29;12(10):929. doi: 10.3390/pharmaceutics12100929.
7
Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer.肿瘤发生中的致癌信号传导及siRNA纳米疗法在乳腺癌中的应用
Cancers (Basel). 2019 May 6;11(5):632. doi: 10.3390/cancers11050632.
8
MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase 1 in breast cancer cells.MicroRNA-424 通过靶向乳腺癌细胞中的细胞周期蛋白依赖性激酶 1 发挥抑癌作用。
Oncol Rep. 2018 Dec;40(6):3416-3426. doi: 10.3892/or.2018.6741. Epub 2018 Sep 27.
9
Controlled in-cell activation of RNA therapeutics using bond-cleaving bio-orthogonal chemistry.利用可裂解生物正交化学对RNA疗法进行细胞内可控激活。
Chem Sci. 2017 Aug 1;8(8):5705-5712. doi: 10.1039/c7sc01380a. Epub 2017 Jun 14.
10
Aberrant expression of CDK8 regulates the malignant phenotype and associated with poor prognosis in human laryngeal squamous cell carcinoma.细胞周期蛋白依赖性激酶8(CDK8)的异常表达调节人喉鳞状细胞癌的恶性表型并与不良预后相关。
Eur Arch Otorhinolaryngol. 2017 May;274(5):2205-2213. doi: 10.1007/s00405-017-4484-0. Epub 2017 Feb 20.

本文引用的文献

1
Exploring potential use of internet, E-mail, and instant text messaging to promote breast health and mammogram use among immigrant Hispanic women in Los Angeles County.探索利用互联网、电子邮件和即时短信来促进洛杉矶县西班牙裔移民妇女的乳房健康及乳房X光检查的使用。
Am Surg. 2013 Oct;79(10):997-1000.
2
Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy.乳腺癌治疗女性的钙和维生素 D 补充与骨密度丢失。
Crit Rev Oncol Hematol. 2013 Dec;88(3):613-24. doi: 10.1016/j.critrevonc.2013.07.002. Epub 2013 Aug 7.
3
Tumor-suppressive effects of CDK8 in endometrial cancer cells.CDK8 在子宫内膜癌细胞中的抑瘤作用。
Cell Cycle. 2013 Mar 15;12(6):987-99. doi: 10.4161/cc.24003. Epub 2013 Mar 1.
4
CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency.CDK8 维持肿瘤去分化和胚胎干细胞多能性。
Cancer Res. 2012 Apr 15;72(8):2129-39. doi: 10.1158/0008-5472.CAN-11-3886. Epub 2012 Feb 16.
5
Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherol.维生素 E 在乳腺癌中的化学预防作用:重点关注 γ-和 δ-生育酚。
Nutrients. 2011 Nov;3(11):962-86. doi: 10.3390/nu3110962. Epub 2011 Nov 14.
6
Cancer statistics, 2012.癌症统计数据,2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
7
CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.470 例结直肠癌中 CDK8 的表达与β-连环蛋白激活、其他分子改变及患者生存的关系。
Int J Cancer. 2010 Jun 15;126(12):2863-73. doi: 10.1002/ijc.24908.
8
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.细胞周期蛋白依赖性激酶8(CDK8)是一种调节β-连环蛋白活性的结直肠癌致癌基因。
Nature. 2008 Sep 25;455(7212):547-51. doi: 10.1038/nature07179. Epub 2008 Sep 14.
9
Inhibitors of cyclin dependent kinases: useful targets for cancer treatment.细胞周期蛋白依赖性激酶抑制剂:癌症治疗的有效靶点。
Curr Cancer Drug Targets. 2008 Feb;8(1):53-75. doi: 10.2174/156800908783497131.
10
CDK8 is a stimulus-specific positive coregulator of p53 target genes.细胞周期蛋白依赖性激酶8是p53靶基因的一种刺激特异性正向共调节因子。
Mol Cell. 2007 Jul 6;27(1):121-33. doi: 10.1016/j.molcel.2007.05.026.